April Emerging Medical Technologies Report

Table of Contents

BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED

• Ablation probe that allows surgeons to perform intra-operative procedure that destroys residual breast cancer cells in minutes instead of weeks
• An innovative diagnostic to detect lymphedema, a side effect of breast cancer surgery impacting nearly 50% of all breast cancer survivors
• An integrated, droplet-based desktop DNA sequencer system
• Biomarker tests to identify individuals at risk of cognitive decline, Alzheimer's disease and other dementias
• Bioresorbable, biocompatible drug-loaded embolic beads that block blood vessels supplying tumors or fibroids without causing long-term blockage of the blood vessels of healthy tissue
• Cervical spine implants and instruments to treat cervical degenerative disc disease through indirect decompression and fusion
• Class II and Class III medical devices used in spinal surgical procedures, including spinal fixation systems, implants, and instruments
• Device for simplifying peritoneal dialysis in the treatment of patients with severe chronic kidney disease
• Dry powder inhaler that uses advanced technology to overcome the drawbacks of current inhalers, for use in the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD)
• Hand hygiene compliance monitoring system for healthcare workers
• Hydrogel wound care solutions and drug delivery technologies
• Laparoscopic devices for closure of port site punctures
• Newborn monitoring and resuscitation technology
• Next-generation sequencing assays that analyze T cells and B cells, which are critical components of the adaptive immune system's defense against disease
• Non-invasive neuromodulation and brain stimulation technology
• Novel ENT medical device which allows tympanostomy tubes (grommets) to be placed safely and quickly in an office setting, eliminating the need for general anesthetic and costly OR time
• Proprietary methods to perform patient-specific genetic analyses of cancer using digital characterization and monitoring technologies
• Technology for testing biomarkers and performing multi-analyte immunoassays
• Test that enables comprehensive sequencing of cancer tumor DNA using a simple blood test without the need for a biopsy
• The first non-implantable, catheter-based therapy to treat the valvular pathophysiology of chronic venous insufficiency in the deep veins
• The world's first affordable, handheld 3D medical scanner, for use in orthotics, prosthetics and plastic surgery, among other applications
• Variable-stiffness microcatheter designed to accelerate interventional procedures by allowing clinicians to more rapidly navigate small, tortuous blood vessels